AR047327A1 - Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables - Google Patents
Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptablesInfo
- Publication number
- AR047327A1 AR047327A1 ARP040104613A ARP040104613A AR047327A1 AR 047327 A1 AR047327 A1 AR 047327A1 AR P040104613 A ARP040104613 A AR P040104613A AR P040104613 A ARP040104613 A AR P040104613A AR 047327 A1 AR047327 A1 AR 047327A1
- Authority
- AR
- Argentina
- Prior art keywords
- dihydro
- oxo
- tetrafluoroborate
- tetramethyluronium
- hexafluorophosphate
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title abstract 3
- 229960002582 perindopril Drugs 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- -1 benzyl ester Chemical class 0.000 abstract 29
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 abstract 6
- 125000005500 uronium group Chemical group 0.000 abstract 6
- WEDDWMBGLITKKJ-UHFFFAOYSA-N 1-(ethyliminomethylideneamino)-n,n'-dimethylpropane-1,3-diamine Chemical compound CCN=C=NC(NC)CCNC WEDDWMBGLITKKJ-UHFFFAOYSA-N 0.000 abstract 5
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract 4
- VUWHVUNQPYWNDG-UHFFFAOYSA-N [dimethylamino-[(4-oxo-1,2,3-benzotriazin-3-yl)oxy]methylidene]-dimethylazanium Chemical compound C1=CC=C2C(=O)N(OC(N(C)C)=[N+](C)C)N=NC2=C1 VUWHVUNQPYWNDG-UHFFFAOYSA-N 0.000 abstract 3
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 abstract 2
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 abstract 2
- SJPCKNGBVSKXNZ-UHFFFAOYSA-N 1-chloro-n,n'-dimethylpropane-1,3-diamine Chemical compound CNCCC(Cl)NC SJPCKNGBVSKXNZ-UHFFFAOYSA-N 0.000 abstract 1
- FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 abstract 1
- WSNFKVVZSAMWRX-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrochloride Chemical compound Cl.C1=CC=C2N(O)N=NC2=C1 WSNFKVVZSAMWRX-UHFFFAOYSA-N 0.000 abstract 1
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 abstract 1
- GOODXEAJZGMZKG-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;hydrochloride Chemical compound Cl.ON1C(=O)CCC1=O GOODXEAJZGMZKG-UHFFFAOYSA-N 0.000 abstract 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 abstract 1
- HJBLUNHMOKFZQX-UHFFFAOYSA-N 3-hydroxy-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N(O)N=NC2=C1 HJBLUNHMOKFZQX-UHFFFAOYSA-N 0.000 abstract 1
- GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 abstract 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 abstract 1
- UZDQOKJOBPKXFP-UHFFFAOYSA-N ON(C(C1=CC=CC=C11)=O)C1=O.Cl Chemical compound ON(C(C1=CC=CC=C11)=O)C1=O.Cl UZDQOKJOBPKXFP-UHFFFAOYSA-N 0.000 abstract 1
- CXYLYDVXZAPDJC-UHFFFAOYSA-N ON1N=NC2=C1N=CC=C2.Cl Chemical compound ON1N=NC2=C1N=CC=C2.Cl CXYLYDVXZAPDJC-UHFFFAOYSA-N 0.000 abstract 1
- VPMAWWKDEFLLBU-UHFFFAOYSA-N [dimethylamino-(2-oxopyridin-1-yl)oxymethylidene]-dimethylazanium Chemical compound CN(C)C(=[N+](C)C)ON1C=CC=CC1=O VPMAWWKDEFLLBU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 abstract 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000007822 coupling agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 1: Procedimiento para la síntesis industrial de perindopril de formula (1), y de sus sales farmacéuticamente aceptables, caracterizado porque el éster bencílico de formula (2) o (3), o una sal de adicion del éster de formula (2) o (3) con un ácido mineral o un ácido orgánico se hace reaccionar con el compuesto de formula (4), en presencia de un agente de acoplamiento seleccionado entre los siguientes reactivos y pares de reactivos: clorhidrato de (1,3-dimetilaminopropil)-3-etil- carbodiimida; clorhidrato de (1,3-dimetilaminopropil)-3-etil-carbodiimida/1-hidroxibenzotriazol; clorhidrato de (1,3-dimetilaminopropil)-3-etil-carbodiimida/1-hidroxi-7-azabenzotriazol; clorhidrato de (1,3-dimetilaminopropil)-3-etil-carbodiimida/N- hidroxisuccinimida; clorhidrato de (1,3-dimetilaminopropil)-3-etil-carbodiimida/3-hidroxi-3,4-dihidro-4-oxo-1,2,3-benzotriazina; clorhidrato de (1,3-dimetilaminopropil)-3-etil-carbodiimida/N-hidroxiftalimida; diciclohexilcarbodiimida/1-hidroxi-7- azabenzotriazol; diciclohexilcarbodiimida/N-hidroxisuccinimida; diciclohexilcarbodiimida/3-hidroxi-3,4-dihidro-4-oxo-1,2,3-benzotriazina; diciclohexilcarbodiimida/ N-hidroxiftalimida; hexafluorofosfato de O-(benzotriazol-1-il)-1,1,3,3- tetrametiluronio; hexafluorofosfato de O-(7-azabenzotriazol-1-il)-1,1,3,3-tetrametiluronio; tetrafluoroborato de O-(benzotriazol-1-il)-1,1,3,3-tetrametiluronio; hexafluorofosfato de benzotriazol-1-il-oxitripirrolidinofosfonio; hexafluorofosfato de benzotriazol-1-il-oxitris(dimetilamino)fosfonio; hexafluorofosfato de O-(benzotriazol-1-il)-1,1,3,3-bis(tetrametilen)uronio; hexafluorofosfato de O-(benzotriazol-1-il)-1,1,3,3-bis(pentametilen)uronio; hexafluorofosfato de cloro- tripirrolidinofosfonio; hexafluorofosfato de cloro-1,1,3,3-bis(tetrametilen)formamidinio; hexafluorofosfato de cloro-1,1,3,3-bis(pentametilen)formamidinio; N-etoxicarbonil-2-etoxi-1,2-dihidroquinoleína; tetrafluoroborato de O-[(etoxicarbonil)- cianometilenamino]-1,1,3,3-tetrametiluronio; tetrafluoroborato de O-(3,4-dihidro-4-oxo-1,2,3-benzotriazin-3-il)-1,1,3,3-tetrametiluronio; tetrafluoroborato de O-(3,4-dihidro-4-oxo-1,2,3-benzotriazin-3-il)-1,1,3,3-tetrametiluronio/1- hidroxibenzotriazol; tetrafluoroborato de O-(3,4-dihidro-4-oxo-1,2,3-benzotriazin-3-il)-1,1,3,3-tetrametiluronio/N-metilmorfolina; tetrafluoroborato de O-(3,4-dihidro-4-oxo-1,2,3-benzotriazin-3-il)-1,1,3,3-tetrametiluronio/colidina; tetrafluoroborato de O-(1,2-dihidro-2-oxo-1-piridil)-1,1,3,3-tetrametiluronio; tetrafluoroborato de O-(1,2-dihidro-2-oxo-1-piridil)-1,1,3,3-tetrametiluronio/1-hidroxibenzotriazol; hexafluorofosfato de O-(1,2-dihidro-2-oxo-1-piridil)-1,1,3,3- bis(tetrametilen)uronio; hexafluorofosfato de O-(1,2-dihidro-2-oxo-1-piridil)-1,1,3,3-bis(tetrametilen)uronio/1-hidroxi-benzotriazol; tetrafluoroborato de O-(N-succinimidil)-1,1,3,3-tetrametiluronio; tetrafluoroborato de O-(N-succinimidil)-1,1,3,3- bis(tetrametilen)uronio; tetrafluoroborato de O-(N-succinimidil)-1,1,3,3-bis(tetrametilen)uronio/1-hidroxi-benzotriazol; tetrafluoroborato de O-(5-norboneno-2,3-dicarboximido)-1,1,3,3,-tetrametiluronio; anhídrido propanofosfonico; imida del ácido N- hidroxi-5-norboneno-2,3-dicarboxílico; y N-hidroxi-1,2-dihidro-2-oxo-piridina; opcionalmente en presencia de una base, para obtener, después de la hidrogenacion catalítica en presencia de paladio, perindopril de formula (1), que se convierte, si se desea, en una sal farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03293084A EP1420029B9 (fr) | 2003-12-10 | 2003-12-10 | Procédé de synthèse du perindopril et ses sels pharmaceutiquement acceptables |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047327A1 true AR047327A1 (es) | 2006-01-18 |
Family
ID=32116381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104613A AR047327A1 (es) | 2003-12-10 | 2004-12-10 | Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7279583B2 (es) |
| EP (1) | EP1420029B9 (es) |
| JP (1) | JP4377413B2 (es) |
| KR (1) | KR100825537B1 (es) |
| CN (1) | CN100453552C (es) |
| AR (1) | AR047327A1 (es) |
| AT (1) | ATE386745T1 (es) |
| AU (1) | AU2004312185B2 (es) |
| BR (1) | BRPI0417423B1 (es) |
| CA (1) | CA2548405C (es) |
| CY (1) | CY1108238T1 (es) |
| DE (1) | DE60319196T2 (es) |
| DK (1) | DK1420029T3 (es) |
| EA (1) | EA012034B1 (es) |
| ES (1) | ES2300555T3 (es) |
| GE (1) | GEP20084370B (es) |
| HK (1) | HK1095839A1 (es) |
| MA (1) | MA28222A1 (es) |
| MY (1) | MY139289A (es) |
| NO (1) | NO20063012L (es) |
| NZ (1) | NZ547550A (es) |
| PL (1) | PL211485B1 (es) |
| PT (1) | PT1420029E (es) |
| SI (1) | SI1420029T1 (es) |
| UA (1) | UA84898C2 (es) |
| WO (1) | WO2005066198A1 (es) |
| ZA (1) | ZA200604369B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2413128A (en) * | 2004-04-13 | 2005-10-19 | Neopharma Ltd | Process for the preparation of perindopril |
| EP1987828A1 (en) * | 2005-01-06 | 2008-11-05 | IPCA Laboratories Limited | salts of perindopril and their use in the therapy of hypertension |
| WO2006131828A1 (en) * | 2005-06-08 | 2006-12-14 | Aurobindo Pharma Limited | A process for the preparation of perindopril |
| ES2552653T3 (es) * | 2008-06-24 | 2015-12-01 | Mylan Laboratories Limited | Formas polimórficas novedosas de (l)-arginina de perindoprilo y proceso para la preparación de las mismas |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
-
2003
- 2003-12-10 DK DK03293084T patent/DK1420029T3/da active
- 2003-12-10 ES ES03293084T patent/ES2300555T3/es not_active Expired - Lifetime
- 2003-12-10 SI SI200331193T patent/SI1420029T1/sl unknown
- 2003-12-10 DE DE60319196T patent/DE60319196T2/de not_active Expired - Lifetime
- 2003-12-10 PT PT03293084T patent/PT1420029E/pt unknown
- 2003-12-10 EP EP03293084A patent/EP1420029B9/fr not_active Expired - Lifetime
- 2003-12-10 AT AT03293084T patent/ATE386745T1/de active
-
2004
- 2004-09-12 UA UAA200607608A patent/UA84898C2/uk unknown
- 2004-12-09 WO PCT/FR2004/003166 patent/WO2005066198A1/fr active Application Filing
- 2004-12-09 EA EA200601086A patent/EA012034B1/ru not_active IP Right Cessation
- 2004-12-09 AU AU2004312185A patent/AU2004312185B2/en not_active Ceased
- 2004-12-09 GE GEAP20049501A patent/GEP20084370B/en unknown
- 2004-12-09 US US10/582,283 patent/US7279583B2/en not_active Expired - Fee Related
- 2004-12-09 BR BRPI0417423A patent/BRPI0417423B1/pt not_active IP Right Cessation
- 2004-12-09 CA CA2548405A patent/CA2548405C/fr not_active Expired - Fee Related
- 2004-12-09 ZA ZA200604369A patent/ZA200604369B/en unknown
- 2004-12-09 NZ NZ547550A patent/NZ547550A/en not_active IP Right Cessation
- 2004-12-09 KR KR1020067013586A patent/KR100825537B1/ko not_active IP Right Cessation
- 2004-12-09 MY MYPI20045097A patent/MY139289A/en unknown
- 2004-12-09 CN CNB2004800363546A patent/CN100453552C/zh not_active Expired - Fee Related
- 2004-12-09 PL PL380410A patent/PL211485B1/pl unknown
- 2004-12-09 JP JP2006543583A patent/JP4377413B2/ja not_active Expired - Fee Related
- 2004-12-10 AR ARP040104613A patent/AR047327A1/es not_active Application Discontinuation
-
2006
- 2006-06-07 MA MA29083A patent/MA28222A1/fr unknown
- 2006-06-28 NO NO20063012A patent/NO20063012L/no not_active Application Discontinuation
-
2007
- 2007-03-20 HK HK07102976.7A patent/HK1095839A1/xx not_active IP Right Cessation
-
2008
- 2008-05-16 CY CY20081100813T patent/CY1108238T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2552338T3 (es) | Compuestos farmacéuticos | |
| US5221752A (en) | α-keto amide derivatives | |
| KR100904829B1 (ko) | 4-아미노피페리딘 유도체 | |
| US5576313A (en) | Inhibitors of farnesyl-protein transferase | |
| CA2717518C (en) | Pyrrolidine derivatives | |
| ES2328405T3 (es) | Piperazina sustituida por 2-aminocarbonil o compuestos diaza-ciclicos como moduladores del inhibidor de la proteina de la apoptosis (iap). | |
| PL200115B1 (pl) | Nowe podstawione indole, lek zawierający nowe podstawione indole oraz zastosowanie nowych podstawionych indoli | |
| JP2005504737A (ja) | Ｎ−（３−アミノ−２−ヒドロキシ−プロピル）置換アルキルアミド化合物 | |
| JPS6327468A (ja) | コレシストキニン拮抗物質としてのアミノ酸アナログ | |
| FR2819254A1 (fr) | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques | |
| TW415945B (en) | Inhibitors of prenyl transferases | |
| AR047327A1 (es) | Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables | |
| EP3280721B1 (en) | Process for preparation of nitrogen mustard derivatives | |
| EP0925281A1 (en) | Peptidyl compounds having mmp and tnf inhibitory activity | |
| Bailén et al. | 2-Mercaptopyridone 1-Oxide-Based Uronium Salts: New Peptide Coupling Reagents1, 2 | |
| Van Rompaey et al. | A versatile synthesis of 2-substituted 4-amino-1, 2, 4, 5-tetrahydro-2-benzazepine-3-ones | |
| JP6333267B2 (ja) | アザインドリン | |
| Russo et al. | Visible-light photocatalytic metal-free multicomponent Ugi-like chemistry | |
| Brinner et al. | Novel and potent anti-malarial agents | |
| Dahlgren et al. | New inhibitors of the malaria aspartyl proteases plasmepsin I and II | |
| JP2007527903A (ja) | インドール−２−カルボン酸ヒドラジド化合物 | |
| ES2255848B1 (es) | Derivados de isoquinolina como inhibidores de calpaina. | |
| JP2004535459A (ja) | プロリルオリゴペプチダーゼ阻害活性を有する化合物、その製造方法ならびにその使用 | |
| WO2012088268A2 (en) | Modulators for sirt6 and assays for screening same | |
| AR047328A1 (es) | Procedimiento para la sintesis de compuestos del acido (2s, 3as, 7as)-1-[(s)-alanil]-octahidro-1h-indol-2-carboxilico y aplicacion en la sintesis de perindopril. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |